Obesity and obesity related co-morbidities have become an increasing public health issue over the past decade due to the many complications that follow suit. Obesity is not only a cosmetic concern, but also a risk factor for several health issues including high blood pressure, diabetes, arthritis, kidney disease, cancers, sleep apnea, stroke, liver disease, chronic pain, and infertility. Due to the numerous complications of obesity, it goes without saying that obesity can decrease your quality of life while also decreasing your life expectancy. Lifestyle and behavioral changes aimed at dieting/weight loss are not always enough to jump start the process. 

GLP-1 agonists such as Semaglutide have been proven to not only improve blood sugar control, but also promote weight loss. GLP-1 agonists delay gastric emptying, allowing for you to feel full for a longer period of time, thus decreasing the quantity and frequency on eating. GLP-1 agonists are a subcutaneous injection administered once a week that can help people lose up to 15-20% of their body weight. GLP-1 agonists will not only help with weight loss, but this medication will also reduce the risk of heart attack, stroke, diabetes, and mortality. 

Are you ready to jump start your weight loss journey? Book a GLP-1 agonists (Semaglutide) consult with us and let this groundbreaking medication support your health goals and transform your life!

References

Wang, J.Y., Wang, Q. W., Yang, X. Y., Yang, W., Li, D.R., Jin, J. Y., Zhang, H. C., & Zhang, X. F. (2023). GLP-1 receptor agonists for the treatment of obesity: Role as a promising approach. Frontiers in endocrinology, 14, 1085799. https://doi.org/10.3389/fendo.2023.1085799